Rapid Fire
Cough Syrup Samples Fail Export Quality Test
- 13 Dec 2023
- 1 min read
Recently, data from the Central Drugs Standard Control Organisation (CDSCO), shows that at least 6% of cough syrup samples from 54 Indian manufacturers failed a mandatory quality test for export.
- Gambia, Uzbekistan, Cameroon, and the World Health Organization (WHO) expressed concerns following the deaths of children who had taken these medications.
- Indian manufactured syrups were reported to be contaminated with glycol and ethylene glycol toxic substances that can sometimes be fatal, especially for children.
- India’s pharmaceutical sector contributes around 1.72% of GDP and the industry is worth approximately USD 50 billion with more than half coming from exports.
- The CDSCO under the Ministry of Health & Family Welfare is a national regulatory authority of India.
Read More: India-made Syrups and Deaths in Gambia
